1. Home
  2. INGR vs PTCT Comparison

INGR vs PTCT Comparison

Compare INGR & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ingredion Incorporated

INGR

Ingredion Incorporated

HOLD

Current Price

$113.63

Market Cap

7.1B

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$71.42

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INGR
PTCT
Founded
1906
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.1B
IPO Year
1997
2013

Fundamental Metrics

Financial Performance
Metric
INGR
PTCT
Price
$113.63
$71.42
Analyst Decision
Hold
Buy
Analyst Count
7
17
Target Price
$134.57
$73.76
AVG Volume (30 Days)
567.5K
1.3M
Earning Date
02-03-2026
02-26-2026
Dividend Yield
2.85%
N/A
EPS Growth
N/A
N/A
EPS
10.01
8.94
Revenue
$7,262,000,000.00
$1,779,150,000.00
Revenue This Year
N/A
$129.80
Revenue Next Year
$1.10
N/A
P/E Ratio
$11.48
$8.11
Revenue Growth
N/A
97.54
52 Week Low
$102.31
$35.95
52 Week High
$141.78
$87.50

Technical Indicators

Market Signals
Indicator
INGR
PTCT
Relative Strength Index (RSI) 57.80 34.81
Support Level $111.87 $73.32
Resistance Level $117.01 $77.87
Average True Range (ATR) 2.08 3.05
MACD 0.38 -0.64
Stochastic Oscillator 68.24 13.31

Price Performance

Historical Comparison
INGR
PTCT

About INGR Ingredion Incorporated

Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty ingredients that include starch-based texturizers and natural alternative sweeteners such as stevia. Ingredion also sells commodity ingredients that include sweeteners, such as high-fructose corn syrup, and starches, such as those used for sustainable packaging, as well as plant-based proteins.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

Share on Social Networks: